Acadian Asset Management LLC Fibrogen Inc Transaction History

Acadian Asset Management LLC

$35.4 Billion
Q1 2025

A detailed history of Acadian Asset Management LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 3,905,350 shares of FGEN stock, worth $30 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,905,350

Previous 3,905,350 -0.0%

Holding current value

$30 Million

Previous $2.07 Million 41.5%

% of portfolio

0.0%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.33 - $1.26 $178,408 - $681,195	540,631 Added 16.07%	3,905,350 $1.56 Million
Q2 2024 Aug 06, 2024	BUY	$0.89 - $2.36 $766,160 - $2.03 Million	860,854 Added 34.38%	3,364,719 $3 Million
Q1 2024 May 10, 2024	BUY	$0.73 - $2.73 $25,504 - $95,378	34,937 Added 1.42%	2,503,865 $5.88 Million
Q4 2023 Feb 13, 2024	BUY	$0.38 - $0.91 $324,456 - $776,988	853,834 Added 52.87%	2,468,928 $2.19 Million
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $1.28 Million - $4.57 Million	1,615,094 New	1,615,094 $1.39 Million
Q1 2022 May 12, 2022	SELL	$12.02 - $16.79 $16,828 - $23,506	-1,400 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$9.93 - $15.39 $13,902 - $21,546	1,400 New	1,400 $19,000
Q3 2021 Nov 12, 2021	SELL	$10.18 - $26.64 $214,808 - $562,130	-21,101 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$18.57 - $35.68 $83,472 - $160,381	4,495 Added 27.07%	21,101 $562,000
Q1 2021 May 11, 2021	BUY	$31.0 - $55.72 $496,031 - $891,575	16,001 Added 2644.79%	16,606 $576,000
Q4 2020 Feb 11, 2021	BUY	$37.09 - $48.97 $22,439 - $29,626	605 New	605 $22,000
Q2 2020 Aug 12, 2020	SELL	$32.57 - $42.83 $21,691 - $28,524	-666 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$23.3 - $45.96 $67,127 - $132,410	-2,881 Reduced 81.22%	666 $23,000
Q4 2019 Feb 06, 2020	BUY	$34.58 - $48.06 $122,655 - $170,468	3,547 New	3,547 $152,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

34.2M

Call Options Held

461K

Put Options Held

102K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $721M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Fibrogen Inc Transaction History